MTOR and systemic lupus erythematosus: Furthermore, mitochondrial membrane hyperpolarization increases the activity of mammalian target of rapamycin (mTOR) in CD4+ T cells from patients with SLE, and rapamycin treatment reduces disease manifestations in these patients 46-49.